XML 51 R30.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Acquisitions (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Acquisitions [Abstract] |
Schedule of Acquisition Date Fair Value of Consideration Transferred | The acquisition date fair value of consideration transferred was calculated as follows:
Net cash transferred |  | $ | 83,888,239 |
Fair value of common stock transferred |  |  | 12,091,142 |
Fair value of consideration transferred |  | $ | 95,979,381 |
Schedule of Estimated Fair Value of Assets Acquired and Liabilities | The following table summarizes the estimated fair value of assets acquired and liabilities assumed at the acquisition date:
Assets Acquired |  |  |
Cash |  | $ | 940,974 |
Accounts receivable |  |  | 6,028,048 |
Taxes receivable |  |  | 1,035,754 |
Prepaid expenses and other |  |  | 912,719 |
Property and equipment |  |  | 33,476 |
Customer relationships intangible |  |  | 34,000,000 |
Trademark and patent intangible |  |  | 5,700,000 |
Technology intangibles |  |  | 8,300,000 |
Operating lease right-of-use assets |  |  | 145,075 |
Deposits |  |  | 9,727 |
|  |  | 57,105,773 |
Liabilities Assumed |  |  |  |
Accounts payable |  |  | 1,997,348 |
Accrued expenses |  |  | 3,848,403 |
Lease liabilities |  |  | 166,098 |
Deferred revenue |  |  | 75,003 |
Deferred tax liabilities |  |  | 12,032,798 |
|  |  | 18,119,650 |
Net assets acquired |  |  | 38,986,123 |
Goodwill |  |  | 56,993,258 |
Fair value of consideration transferred |  | $ | 95,979,381 |
Schedule of Identifiable Intangibles are Being Amortized on a Straight Line Basis | The identifiable intangibles are being amortized on a straight line basis over the following estimated useful lives:
Customer relationship intangible |  | 15 years
Trademark and patent intangible |  | 10 years
Technology intangibles |  | 4 to 10 years
Schedule of Pro-Forma Consolidated Statement of Operations as if Medicx Health | The amounts of revenue and net income of Medicx Health included in the Company’s consolidated statement of operations for the period from the acquisition date until December 31, 2023, are as follows:
Revenue |  | $ | 4,546,497 |
Net income |  |  | 314,082 |
Schedule of Pro-Forma Consolidated Statement of Operations | The following represents the pro-forma consolidated statement of operations as if Medicx Health had been included in the consolidated results of the Company for the full years ended December 31, 2023, and 2022:
|  | Year ended December 31, 2022 |
Pro-forma consolidated statement of operations |  | 2023 |  |  | 2022 |
Revenue |  | $ | 97,066,241 |  |  | $ | 90,521,236 |
Net loss |  |  | (18,616,303 | ) |  |  | (16,157,521 | )

X
- References No definition available. + Details
Name: | oprx_ProFormaConsolidatedStatementOfOperationsTableTextBlock
Namespace Prefix: | oprx_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph (a) -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AssetAcquisitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1 + Details
Name: | us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Paragraph 1 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration